Affichage 1 à 9 des 9 essais cliniques
ESSAI CLINIQUE No essai ClinicalTrials.gov ID |
Investigateur(trice) principal(e)
Coordonnateur(rice) |
||
---|---|---|---|
Banque des cellules leucémique du Québec
banque cellules leucémique ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Dr Marc Lalancette Marie-Pierre Brochu 418-525-4444 poste 15768 |
(EN) A Phase 1 Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
LOXO-IDH-20001 NCT04603001 ![]() |
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
![]() |
Leucémie myéloïde aiguë (LMA) Syndrome myélodysplasique |
Dre Sarit Assouline |
(EN) A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Previously Untreated Patients With TP53 Mutant Acute Myeloid Leukemia
ENHANCE-2 NCT04778397 ![]() |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Dre Julie Bergeron Julie Trinh Lu 514-252-3400 poste 3336 |
(EN) Randomized, Open-label, 2-Arm, Multicenter, Phase 3 Study of Venetoclax and Azacitidine Versus Best Supportive Care as Maintenance Therapy for Patients With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
M19-708 (VIALE-M) NCT04102020 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Leucémie myéloïde aiguë (LMA) |
Dr John Storring |
Banque des cellules leucémique du Québec
banque cellules leucémique ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Dr Robert Delage Linda Vallée 418-649-0252 poste 66602 |
(EN) A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) With ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD)
CTTC 1901 NCT04202835 ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Dre Geneviève Gallagher Philippe Nadeau 418-649-0252 poste 63115 |
(EN) An Exploratory Phase 1/2 Open-Label Multi-Arm Trial to Evaluate the Safety and Efficacy of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
CC-90009-AML-002 NCT04336982 ![]() |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Dre Julie Bergeron Julie Trinh Lu 514-252-3400 poste 3336 |
(EN) A First-In-Human, Open-Label, Multicenter Study of VOR33 in Patients With Acute Myeloid Leukemia Who Are at High-Risk for Leukemia Relapse Following Hematopoietic Cell Transplantation
VBP101 NCT04849910 ![]() |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
![]() |
Leucémie myéloïde aiguë (LMA) |
Dre Nadia Bambace Olivier Cormier 514-252-3400 poste 5966 |
(EN) A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine After Allogeneic Stem Cell Transplantation in Subjects With Acute Myeloid Leukemia
VIALE-T NCT04161885 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Leucémie myéloïde aiguë (LMA) |
Dre Gizelle Propadi Judit Kokai 438-888-1582 |